Not available
Quote | ReShape Lifesciences Inc. (OTCMKTS:RSLS)
Last: | $6.40 |
---|---|
Change Percent: | 16.36% |
Open: | $5.3 |
Close: | $6.40 |
High: | $6.475 |
Low: | $5.11 |
Volume: | 3,774 |
Last Trade Date Time: | 06/15/2021 04:42:04 am |
News | ReShape Lifesciences Inc. (OTCMKTS:RSLS)
Completed First Surgeries With Next-Generation Lap-Band ® 2.0 FLEX 2024 Operating Expenses Expected to Decrease by more than 50% Compared to 2023; Reaffirming Commitment to Profitability Conference Call to be Held at 4:30 pm ET Today IRVINE, Calif., April 01, 2024...
2024-03-28 08:56:46 ET More on ReShape Lifesciences ReShape Lifesciences sees 55.4% fall in Y/Y expenses in 2024 with cost cut plan Seeking Alpha’s Quant Rating on ReShape Lifesciences Historical earnings data for ReShape Lifesciences Financial informa...
Message Board Posts | ReShape Lifesciences Inc. (OTCMKTS:RSLS)
Subject | By | Source | When |
---|---|---|---|
RSLS: Hey, interesting NEWS spot there, Boss! OBESITY[/colo | Invest-in-America | investorshub | 06/27/2023 12:33:26 AM |
Hey! You didn't miss much today pretty dull. | subslover | investorshub | 06/27/2023 12:22:30 AM |
$RSLS: Monster THANKS, Capt. S-L, for the heads-up!!! | Invest-in-America | investorshub | 06/26/2023 10:56:27 PM |
NEWS ReShape Lifesciences Submits FDA PMA Supplement Application for | subslover | investorshub | 06/26/2023 8:30:10 PM |
$RSLS Long and strong lets hope im right | Bigstud is here | investorshub | 06/26/2023 1:22:27 AM |
News, Short Squeeze, Breakout and More Instantly...
ReShape Lifesciences Inc. Company Name:
RSLS Stock Symbol:
OTCMKTS Market:
Completed First Surgeries With Next-Generation Lap-Band ® 2.0 FLEX 2024 Operating Expenses Expected to Decrease by more than 50% Compared to 2023; Reaffirming Commitment to Profitability Conference Call to be Held at 4:30 pm ET Today IRVINE, Calif., April 01, 2024...
IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (NASDAQ:RSLS), the premier physician-led weight loss and metabolic...
IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that the company has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for...